Showing 1361-1370 of 5801 results for "".
A Case Study in Selling a Dermatology Practice
https://practicaldermatology.com/topics/practice-management/a-case-study-in-selling-a-dermatology-practice/27166/Clint Bundy, an M&A advisor specializing in physician practices, talks with Dr. Alison Moon, a distinguished physician and former owner of First Coast Dermatology, about the process of the sale of her practice.When and How to Use Ancillary Testing
https://practicaldermatology.com/programs/practical-dermatology-updates-in-skin-cancer/when-and-how-to-use-ancillary-testing/35598/Hadas Skupsky, MD, a board-certified dermatologist and dermatopathologist, discusses when a dermatopathologist decides to use ancillary testing for melanoma, how that impacts final diagnosis, and how it can guide treatment decisions.Addressing Skin Changes During Menopause: An Update
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/addressing-skin-changes-during-menopause-an-update/20220/New York City-based dermatologist Ellen Gendler, MD, shares pearls from her recent talk at the 2023 annual meeting of the Menopause Society including the current thinking on how to address the effects of diminished estrogen on skin.Biologics in Pediatric Dermatology
https://practicaldermatology.com/topics/psoriasis/biologics-in-pediatric-dermatology/23198/Younger patients are finally gaining access to a range of highly targeted treatments with lower risk profiles than their traditional alternatives.Terminating Patients: Tips for Letting Go of Difficult Clients
https://practicaldermatology.com/topics/practice-management/terminating-patients/20443/An ethical and fair “How-To” for terminating physician-patient relationships.One-and-Done Tattoo Removal: Is It Possible With Q-switched Technology?
https://practicaldermatology.com/topics/practice-management/one-and-done-tattoo-removal-is-it-possible-with-q-switched-technology/21019/Newer and more powerful nanosecond lasers coupled with improved techniques have greatly improved the ability to clear tattoos faster and treat resistant colors.Increasing Patient Satisfaction with Aesthetic Procedures
https://practicaldermatology.com/topics/skin-cancer-photoprotection/increasing-patient-satisfaction-with-aesthetic-procedures/21085/To enhance patient satisfaction, focus on optimizing the patient experience in all phases of care.Dupixent Approved for Spontaneous Urticaria
https://practicaldermatology.com/series/dermwire-tv/dupixent-approved-for-spontaneous-urticaria/35635/In this week's DermwireTV, the FDA approves the first new therapy for spontaneous urticaria in more than 10 years; a new study examines investigational oral Icotrokinra in adolescents with plaque psoriasis; and Practical Dermatology launches a new series addressing trends and innovations in the treaThe Impact of Clascoterone Topical Cream, 1%
https://practicaldermatology.com/issues/april-2025/the-impact-of-clascoterone-topical-cream-1/35605/Clascoterone topical cream, 1% (Winlevi, Sun Pharmaceuticals, Inc.) approved by the US Food and Drug Administration (FDA) in 2020 as the first novel drug introduced for the treatment of acne vulgaris since 1982, is indicated in the US for patients 12 years of age and older.Psoriasis Update 2025: Dr. Gelfand
https://practicaldermatology.com/conferences/maui-derm-hawaii-2025/psoriasis-update-2025-dr-gelfand/32672/Joel Gelfand, MD, MSCE, discusses highlights from the "Psoriasis Update 2025" panel at Maui Derm 2025, including the potential for combining TNF inhibitors with IL-23 inhibitors; home phototherapy; and the possibility of GLP-1 agonists lowering the severity of psoriatic disease.